US Broker Ratings

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 34% Potential Upside for Investors

Zoetis Inc. (NYSE: ZTS), a leading player in the healthcare sector, specifically within the drug manufacturers – specialty & generic industry, stands as a compelling consideration..

CVS Health Corporation (CVS) Stock Analysis: Unlocking a 30.89% Upside Potential in Healthcare

As CVS Health Corporation (NYSE: CVS) continues to solidify its presence in the healthcare sector, individual investors are presented with an interesting opportunity to explore a..

Amgen Inc. (AMGN) Stock Analysis: Navigating Growth with a Robust Pipeline and a 2.61% Dividend Yield

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to capture the attention of investors with its robust portfolio of therapeutics and promising financial..

Abbott Laboratories (ABT) Stock Analysis: Robust Growth and a 17% Upside Potential Beckon Investors

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor interest with its impressive market cap of $178.73 billion and a robust..

Novartis AG (NVS) Investor Outlook: Evaluating the 11.53% Potential Upside and Robust Dividend Yield

Novartis AG (NYSE: NVS), a powerhouse in the healthcare sector, operates within the global pharmaceutical landscape. With its market capitalization standing at an impressive $266.8 billion,..

Boston Scientific Corporation (BSX) Stock Analysis: Unveiling a 42.5% Upside Potential for Investors

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector specializing in medical devices, offers a compelling investment case with a significant upside potential..

Johnson & Johnson (JNJ) Stock Analysis: Navigating through Healthcare with a Robust Growth and Dividend Outlook

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture investor attention with its expansive market cap of $650.65 billion. As a..

MBX Biosciences, Inc. (MBX)

⚠️ No article content returned.

..

Kamada Ltd. (KMDA) Stock Analysis: A Healthcare Gem with 55.71% Potential Upside

Kamada Ltd. (NASDAQ: KMDA), an Israel-based healthcare company specializing in plasma-derived protein therapeutics, is garnering attention from investors due to its robust revenue growth and promising..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A Clinical-Stage Biotech with a 49.90% Upside Potential

Rapport Therapeutics, Inc. (RAPP), a clinical-stage biotechnology firm headquartered in Boston, Massachusetts, is gaining traction among investors due to its promising pipeline and significant potential upside...

AngioDynamics, Inc. (ANGO) Stock Analysis: Potential 30% Upside Amid Strong Buy Ratings

AngioDynamics, Inc. (NASDAQ: ANGO) is garnering attention among healthcare investors as it stands poised for potential growth, driven by strategic advancements in medical technology. With a..

Prothena Corporation plc (PRTA) Stock Analysis: Unveiling a 153% Upside Potential Amidst Biotech Challenges

Prothena Corporation plc (NASDAQ: PRTA), a biotechnology firm headquartered in Dublin, Ireland, is capturing the attention of investors with an impressive potential upside of 152.96%. Specializing..

Celcuity Inc. (CELC) Stock Analysis: Unpacking an 89.32% Potential Upside in Biotech

Investors looking for high potential in the biotechnology sector should take note of Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotech company with a strong focus on..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A 58.6% Potential Upside Beckons Biotech Investors

Oruka Therapeutics, Inc. (NASDAQ: ORKA) is capturing the attention of savvy investors in the biotechnology sector with its groundbreaking work in monoclonal antibody therapeutics. As a..

Oric Pharmaceuticals (ORIC) Stock Analysis: A 60% Upside Potential with Strong Buy Ratings in Biotech

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is capturing investor attention with its promising potential for substantial upside. As a clinical-stage biopharmaceutical firm, Oric focuses on developing innovative..

Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring a 50% Upside Potential

Orthofix Medical Inc. (NASDAQ: OFIX) is positioning itself as a compelling opportunity within the healthcare sector, specifically in the medical devices industry. With a market capitalization..

Abivax SA (ABVX) Stock Analysis: Exploring a 54% Potential Upside in the Biotech Sector

Abivax SA (ABVX), a clinical-stage biotechnology company headquartered in Paris, France, is capturing the attention of investors with a substantial potential upside of 54.22%. Specializing in..

Definitive Healthcare Corp. (DH) Stock Analysis: Unveiling a 98% Upside Potential Despite Current Challenges

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services sector, presents a captivating case for investors willing to delve into a company..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Tapping into a 24.82% Upside Potential

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is making waves in the healthcare sector, especially within the niche of specialty and generic drug manufacturing. With a market capitalization..

COMPASS Pathways Plc (CMPS) Stock Analysis: Strong Buy Ratings and 58% Upside Potential

COMPASS Pathways Plc (CMPS) is making waves in the healthcare sector with its innovative approach to mental health treatment. As a biotechnology company headquartered in London,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds